β¨ Medicines Consents
22 NOVEMBER 2012 NEW ZEALAND GAZETTE, No. 139 4047
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.12g/L equivalent to Noradrenaline base 0.06g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2012.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.159g/L equivalent to Noradrenaline base 0.08g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2012.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.199g/L equivalent to Noradrenaline base 0.1g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2012.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.239g/L equivalent to Noradrenaline base 0.12g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2012.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.319g/L equivalent to Noradrenaline base 0.16g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2012.
Dated this 15th day of November 2012.
DR PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7553
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Perindopril
Active Ingredient: Perindopril erbumine 2mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturers: Apotex Inc, Ontario, Canada
Apotex Research Private Limited, Bangalore, India
Product: Apo-Perindopril
Active Ingredient: Perindopril erbumine 4mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturers: Apotex Inc, Ontario, Canada
Apotex Research Private Limited, Bangalore, India
Next Page →
β¨ LLM interpretation of page content
π₯ Renewal of Provisional Consent to the Distribution of Medicines
π₯ Health & Social Welfare15 November 2012
Medicines Act 1981, Provisional Consent, Noradrenaline Tartrate, Biomed Limited, Auckland
- Dr Pat Tuohy, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New Medicines, Apo-Perindopril, Apotex NZ Limited, Apotex Inc, Apotex Research Private Limited
NZ Gazette 2012, No 139